New research indicates that patients who come off new slimming jabs like Mounjaro or Wegovy may regain lost weight far faster than those who stop conventional diet and exercise regimens.
Findings released in a leading medical journal demonstrates that while overweight people can lose substantial amounts of their body weight while using the jabs, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.
"Individuals buying such treatments need to be informed of the danger of quick rebound weight gain when the medication concludes," stated researcher Dr. Susan Jebb.
This pace of regain suggests a reversion to starting mass in about 18 months.
Analyzing Therapies
The research, which reviewed dozens of studies involving thousands of patients, contrasted the effects of GLP-1 agonists with conventional dieting.
The team note that individuals who shed pounds through lifestyle changes alone typically experience a slower weight regain—approximately 0.1 kg a month—after stopping.
Understanding the Quick Regain
Nutrition scientists suggest the way of the drugs is key to understanding the accelerated regain.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Long-term administration of the hormone levels far above than normal could lead to the body to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this GLP-1 'fix' leads to hunger is uncontrolled, making overeating much more probable."
A Lifelong Condition?
Health authorities suggest the jabs for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
A number of clinicians contend that, due to the significant potential of weight regain, the treatment should be considered ongoing.
This perspective is supported by drug manufacturers, who say that the findings "highlight the chronic nature of excess weight," comparing it to managing conditions like diabetes.
Patient Testimonies
Individuals who have discontinued the medication report a sudden return of hunger.
"I experienced something flipping and you become starving," recalled one woman.
This difficulty is worsened if users have not developed lasting lifestyle or habit modifications during therapy.
Widespread Interest
Recent estimates show that millions of adults in the UK have tried these injections in the last 12 months, with desire being substantial.
- Use is greater among females compared to men.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion access the drugs through private prescriptions rather than the NHS.
In conclusion, researchers stress that while GLP-1 drugs are potent tools for weight loss, they are not a magic fix and lasting health benefits relies on ongoing lifestyle changes.
